The FDA has just updated its Medical Device Shortages List (MDSL), and the headline looks reassuring at first glance: the list is shorter than it's been in years. But a second, less-publicized detail is more relevant to day-to-day procurement planning for dental and medical practices — a sharp rise in the number of devices manufacturers are permanently discontinuing.
What Changed
The FDA trims its shortage list to just a handful of devices, while quietly flagging over 140 products manufacturers are discontinuing this year. The MDSL was originally created during the COVID-19 pandemic; it was first published in early 2021 to help bring greater transparency regarding the availability of critical medical devices, and the initial list identified more than 20 devices for which limited supplies were available, including ventilators, specimen collection devices, and personal protective equipment.
Today, that active shortage list has narrowed considerably. The updated MDSL now lists just 6 separate devices, including 2 surgery-specific devices and 2 intended to provide cardiovascular circulatory support. Earlier in the year, updates to the list added stereotactic breast biopsy needles and angiographic control syringes with rotating adapters, bringing the medical device shortage list to a total of six product codes. Separately, the FDA also flagged an unrelated shortage this spring: a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, expected to continue through the end of the year.
Why the Discontinuance List Matters More
A shrinking active-shortage list is good news, but it doesn't mean supply chains are fully stable. The much longer discontinuance list — devices manufacturers are pulling from the market entirely, rather than temporarily struggling to produce — is a better early-warning signal for practices. When a product code is discontinued, buyers don't just face a delay; they face a permanent sourcing change, often with little advance notice unless someone is actively tracking the FDA's postings.
For dental offices, oral surgery centers, and outpatient medical clinics, this matters less for headline items like ventilators and more for the specialty consumables and instrument components tucked into discontinuance filings each quarter — items that may not make the news but can quietly disrupt a procedure schedule if a preferred SKU disappears without warning.
Practical Steps for Practices
- Review the FDA's MDSL and discontinuance list periodically — both are public and updated regularly, not just during declared emergencies.
- Ask distributors about lead times for any specialty instruments, biopsy or surgical accessories, or circulatory/infection-control devices your practice depends on.
- Avoid single-source dependency on niche product codes where possible, especially for items tied to product codes that have appeared on FDA watch lists in the past.
- Build modest buffer stock for critical, hard-to-substitute items rather than relying purely on just-in-time ordering.
The broader takeaway for 2026: device supply volatility hasn't disappeared, it's just shifted form — from acute pandemic-era shortages to a steadier drumbeat of manufacturer discontinuations. Practices that build a habit of monitoring these updates will be better positioned to adapt before a disruption affects patient care.